Akron Bio has been a leading contract manufacturer in the pharmaceutical sector since 2006, specializing in ancillary materials for the cell and gene therapy industry. The company plays a critical role in advancing life-saving therapies by ensuring a reliable supply of high-quality, well-documented materials. Akron Bio has pioneered innovations such as shelf-stable liquid cytokines and virus-inactivated plasma to enhance product consistency, safety, and performance. Further strengthening its position, the company has invested in a state-of-the-art plasmid DNA manufacturing facility to address industry bottlenecks, supporting both ex vivo and in vivo
Akron Bio has been a leading contract manufacturer in the pharmaceutical sector since 2006, specializing in ancillary materials for the cell and gene therapy industry. The company plays a critical role in advancing life-saving therapies by ensuring a reliable supply of high-quality, well-documented materials. Akron Bio has pioneered innovations such as shelf-stable liquid cytokines and virus-inactivated plasma to enhance product consistency, safety, and performance. Further strengthening its position, the company has invested in a state-of-the-art plasmid DNA manufacturing facility to address industry bottlenecks, supporting both ex vivo and in vivo applications.
With a team of industry leaders and a distinguished scientific advisory board, Akron Bio is committed to driving medical innovation. Its comprehensive portfolio includes cytokines, plasma-derived products, and custom development and manufacturing services, all backed by exceptional technical expertise and customer support. At its core, Akron Bio’s mission is about people—its dedicated team, collaborative customers, and the patients who benefit from its groundbreaking work. By integrating scientific excellence with a patient-centered approach, Akron Bio continues to power the future of medicine.
